[1] 李荣霖,张大鹏,钟玉川,等.急性重症胆管炎患者手术前后血清炎性因子的变化及意义.中国实验诊断学,2015,19(10):1705-1707. [2] Shinya S, Sasaki T, Yamashita Y, et al. Procalcitonin as a useful biomarker for determining the need toperform emergency biliary drainage in cases of acute cholangitis. J Hepatobiliary Pancreat Sci, 2014 ,21(10):777-785. [3] 余珈漫,陆怡德. PCT、hs-CRP及SAA检测在感染性疾病诊断中的临床应用价值. 实用检验医师杂志,2014,6(4):207-211. [4] 李荣,彭开勤,朱国超,等.降钙素原指导下减少腹部外科感染抗生素使用的临床研究. 腹部外科,2016,29(5):388-391. [5] Schneider J,Hapfelmeier A,Thres S,et al. Mrtality risk for acute cholangitis(MAC):a risk prediction model for in-hospital mortality in patients with acute cholangitis. BMC Gastroenterol,2016,16(1):1-8. [6] 范迪欢,邬善敏. 血清降钙素原对急性胆管炎病情早期诊断及预后评估的临床价值. 临床急诊杂志,2017,18(4):256-259. [7] 董慧敏,宋志兴,朱远航,等. 联合检测降钙素原和C-反应蛋白在指导术后感染抗生素应用的价值. 中国卫生检验杂志,2016,26(3):375-377. [8] George DA, Khan M, Haddad FS. Periprosthetic joint infection in total hiparthroplasty: prevention and management. Brit J Hosp Med,2015,76(1):12-17. [9] Villanueva MP, Mollar A, Palau P, et al. Procalcitonin and long-term prognosis after an admission for acute heart failure. Eur J Intern Med, 2015,26(1):42-48. [10] Yan ST, Sun LC, Jia HB, et al. Procalcitonin levels in bloodstream infections caused by different sources and species of bacteria. Am J Emerg Med, 2017,35(4):579-583. [11] Lin J, Sun H, Li J, et al. Role of presepsin for the assessment of acute cholangitis severity. Clin Lab, 2016,62(4):679-687. [12] Zhou F,Hongjun K,Hui L,et al. Early serum procalcitonin, CRP and BNP in the evaluation of prognosis on patients with sepsis. Crit Care Med2015,43(12 Suppl 1):277-277. [13] 孙安民,王伟. 外周血高敏C-反应蛋白和淀粉样蛋白A联合检测的临床价值. 中国卫生检验杂志,2015,25(15):2539-2540,2544. [14] 沈国新,张国雷. 血清淀粉样物质A在急性重症胆管炎治疗中的临床意义. 肝胆胰外科杂志,2013,25(6):512-513. [15] Trásy D,Tánczos K,Németh M,et al. Delta procalcitonin is a better indicator of infection than absolute procalcitonin values in critically Ill patients:a prospective observational study. J Immunol Res,2016,2016:3530752. [16] 卯建,赵滢,代蓉蓉,等. 降钙素原、超敏C-反应蛋白和淀粉样蛋白检测在细菌性感染诊断中的应用价值.昆明医科大学学报,2013,34(7):79-82. |